Havrix

— THERAPEUTIC DISORDERS TREATED —
  • Vaccines

Havrix Generic Name & Formulations

General Description

Hepatitis A vaccine, inactivated 720 ELISA Units (EL.U.) per 0.5mL (pediatric), or 1440 EL.U. per 1mL (adult); susp for IM inj; aluminum adsorbed; contains neomycin (trace); preservative-free.

How Supplied

Single-dose vials—10; Single-dose prefilled Tip-Lok syringes—5 (without needles)

Manufacturer

Havrix Indications

Indications

Hepatitis A immunization.

Havrix Dosage and Administration

Adult

Inject into deltoid, preferably at least 2 weeks before expected exposure. >18yrs: 1440 EL.U. once IM; give booster dose 6–12 months after initial course.

Children

Inject IM preferably at least 2 weeks before expected exposure. <12months: not recommended. 12months–18yrs: 720 EL.U. once IM; give booster dose 6–12months after initial course.

Havrix Contraindications

Contraindications

Neomycin allergy. Previous hypersensitivity reaction to hepatitis A-containing vaccine.

Havrix Boxed Warnings

Not Applicable

Havrix Warnings/Precautions

Warnings/Precautions

Have epinephrine (1:1000) inj available. Fever. Bleeding disorders. Immunodeficiency (may have suboptimal response). If given with immune globulin, use separate syringe and different site. Latex allergy. Pregnancy (Cat.C). Nursing mothers.

Havrix Pharmacokinetics

See Literature

Havrix Interactions

Interactions

Immunosuppressives may reduce efficacy. Concomitant vaccines: see literature.

Havrix Adverse Reactions

Adverse Reactions

Inj site reactions, headache, fatigue, fever, malaise, anorexia, GI upset.

Havrix Clinical Trials

See Literature

Havrix Note

Not Applicable

Havrix Patient Counseling

See Literature